Form 4 for CGON CG Oncology, Inc.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0002007101-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-04 | CGON | Kuan Arthur | CEO, Dir | M - OptEx | $1.72 | +102.9K | 139.0K | +285% | +$176.9K |
| D | 2026-03-06 | 2026-03-04 | CGON | Kuan Arthur | CEO, Dir | F - Tax | $61.61 | -2,871 | 136.2K | -2% | -$176.9K |
| D | 2026-03-06 | 2026-03-04 | CGON | Kuan Arthur | CEO, Dir | M - OptEx | $0.00 | -102.9K | 64.6K | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | M | A | 102,871 | $1.72 | 139,022 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-04 | F | D | 2,871 | $61.61 | 136,151 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2026-03-04 | M | D | 102,871 | $0.00 | 64,612 | D | $1.72 · — to 2031-04-18 | 102,871 Common Stock | (F2) The stock option is currently vested and exercisable. |